Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline. V. Go dicke, F. Hundt. Allergy 2010; 65: 1499 – 1505. (Acceso libre). Este artículo reseña y discute la nueva guía de la Agencia Médica Europea (EMA) acerca de los ensayos clínicos para inmunoterapia alergeno-específica. Ver más…
Role of immunomodulators in allergen-specific immunotherapy
M. V. Kopp.
Allergy Vol. 66 (3). Published online: 18 FEB 2011.
The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy
P. Devillier, M. Le Gall and F. Horak
Allergy Volume 66, Issue 2, pages 163–169, February 2011
Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
S. R. Durham, A. O. Birk and J. S. Andersen
Allergy Volume 66, Issue 1, pages 120–123, January 2011
Patient characteristics associated with allergen immunotherapy initiation and adherence
Cheryl S. Hankin, Richard F. Lockey
Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 46-48, January 2011
The impact of molecular biology on allergen immunotherapy
Bush, Robert K
Current Opinion in Allergy & Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 557–558
Functional regulatory T cells and allergen immunotherapy
Rolland, Jennifer M; Gardner, Leanne M; O’Hehir, Robyn E
Current Opinion in Allergy and Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 559–566
Acceso Libre
